Drug
Idp 118 Lotion
Idp 118 Lotion: highest development phase Post-Market, developed by Bausch Health. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| IDP-118 Lotion NCT03988439 | Post-Market | Psoriasis |
| IDP-118 Lotion NCT02462122 | Phase 3 | Plaque Psoriasis |
| IDP-118 Lotion NCT02785159 | Phase 2 | Psoriasis |
Latest
Follow Idp 118 Lotion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.